Patents by Inventor Frank Bergmann

Frank Bergmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250361549
    Abstract: The invention includes improved methods and compositions for reduction of a C5-C6 double bond of a cytosine. In particular, the improved methods and compositions for reduction of a C5-C6 double bond of a cytosine is via enzymatic means, not via chemical means. In particular, the disclosure is directed to methods of converting 5,6-dihydro-fC (fC) and/or 5,6-dihydro-caC to 5,6-dihydro-U (DHU). In particular, the disclosure is directed to methods of converting 5fC and/or 5caC to DHU. In addition, the disclosure is directed to methods for detection of epigenetic cytosine modification, particularly cytosine methylation, using ene reductases to reduce the C5-C6 double bond of cytosine.
    Type: Application
    Filed: June 12, 2023
    Publication date: November 27, 2025
    Inventors: Dieter Heindl, Frank Bergmann, Shwu shin Chang
  • Publication number: 20250346950
    Abstract: The disclosure relates to tagged nucleoside compounds comprising a nucleotide polyphosphate covalentiy attached to a tag, wherein the compound is a polymerase substrate and the polymer moiety is capable of entering a nanopore linked to the polymerase and thereby altering the flow of ions through the nanopore. The disclosure also provides methods for preparing the tagged nucleoside compounds and for their use as tags in nanopore-based nucleic acid detection and sequencing.
    Type: Application
    Filed: March 13, 2025
    Publication date: November 13, 2025
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Peter J. Crisalli, Sara Kelley, Omid Khakshoor, Hannes Kuchelmeister, Meng Taing
  • Patent number: 12415831
    Abstract: The present disclosure relates to the use of a capping and capture reagent in solid phase peptide synthesis. The present disclosure further relates to a method of solid phase peptide synthesis, wherein a capping and capture reagent according to the present disclosure is used. The present disclosure further relates to a method for purification of a (full-length) synthetic peptide via use of a capping and capture reagent according to the present disclosure. The present disclosure also relates to a kit comprising a capping and capture reagent according to the present disclosure and an amino oxy resin or a hydrazine resin and the use of the kit.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: September 16, 2025
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Frank Bergmann, Sebastian Johannes Pomplun
  • Publication number: 20250283145
    Abstract: The invention includes improved methods and compositions for detecting methylation in nucleic acids. In particular, the disclosure is directed to methods of converting 5-hydroxymethylcytosine (5hmC) and/or 5-methylcytosine (5mC) to Thymine (T). In addition, the disclosure is also directed to methods of detecting 5hmC and/or 5mC in a sample.
    Type: Application
    Filed: February 8, 2022
    Publication date: September 11, 2025
    Inventors: Frank Bergmann, Shwu shin Chang, Peter Crisalli, Abre De Beer, Dieter Heindl, Omid Khakshoor, David Lawrence Penkler, Jo-Anne Elizabeth Penkler, Martin Ranik, Meng Taing
  • Publication number: 20250283818
    Abstract: The present invention relates to a method for determining at least one analyte of interest and the uses thereof. The present invention further relates to a diagnostic system, a kit and the use thereof for determining at least one analyte of interest.
    Type: Application
    Filed: May 23, 2025
    Publication date: September 11, 2025
    Inventors: Frank Bergmann, Kay Hagedorn, Dieter Heindl, Martin Rempt
  • Publication number: 20250178271
    Abstract: The present disclosure relates to a method for transferring an embossed structure to at least a part of a surface of a coating (B2), using a composite (F1B1) composed of a substrate (F1) and of an at least partially embossed and at least partially cured coating (B1), where the coating (B2) and the coating (B1) of the composite (F1B1) have embossed structures which are mirror images of one another. Also described herein is a composite (B2B1F1). Further described herein is a use of this composite for producing an at least partially embossed coating (B2) in the form of a free film or a composite (B2KF2) composed of a substrate (F2), at least one adhesive (K), and the coating (B2).
    Type: Application
    Filed: February 6, 2025
    Publication date: June 5, 2025
    Inventors: Jan-Bernd KUES, Susanne PIONTEK, Joerg EXNER, Joerg LENZ, Birgit KLEINE-BLEY, Wilfried SCHIPPER, Robert VON DER AA, Frank BERGMANN, Michael LORENZ, Sven Olle KRABBENBORG, Joerg DUENNEWALD
  • Patent number: 12269202
    Abstract: The present disclosure relates to a method for transferring an embossed structure to at least a part of a surface of a coating (B2), using a composite (F1B1) composed of a substrate (F1) and of an at least partially embossed and at least partially cured coating (B1), where the coating (B2) and the coating (B1) of the composite (F1B1) have embossed structures which are mirror images of one another. Also described herein is a composite (B2B1F1). Further described herein is a use of this composite for producing an at least partially embossed coating (B2) in the form of a free film or a composite (B2KF2) composed of a substrate (F2), at least one adhesive (K), and the coating (B2).
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: April 8, 2025
    Assignee: BASF COATINGS GMBH
    Inventors: Jan-Bernd Kues, Susanne Piontek, Joerg Exner, Joerg Lenz, Birgit Kleine-Bley, Wilfried Schipper, Robert von der AA, Frank Bergmann, Michael Lorenz, Sven Olle Krabbenborg, Joerg Duennewald
  • Patent number: 12270075
    Abstract: The disclosure relates to tagged nucleoside compounds comprising a nucleotide polyphosphate covalently attached to a tag, wherein the compound is a polymerase substrate and the polymer moiety is capable of entering a nanopore linked to the polymerase and thereby altering the flow of ions through the nanopore. The disclosure also provides methods for preparing the tagged nucleoside compounds and for their use as tags in nanopore-based nucleic acid detection and sequencing.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: April 8, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Peter J. Crisalli, Sara Kelley, Omid Khakshoor, Hannes Kuchelmeister, Meng Taing
  • Publication number: 20240300900
    Abstract: The invention relates in a first aspect to an azadibenzocyclooctyne derivative according to formula (I) or a salt thereof having specific substituents at the benzo rings of the DIBAC structure and having specific substituents connected to the nitrogen atom of the DIBAC structure. A second aspect of the invention is directed to a conjugate of formula (II), wherein a substituent R6 is connected to the N atom of the 8 membered ring of the DIBAC structure via a linker structure —C(?O)-[L]n-Z—. A third aspect of the invention relates to a method for the modification of a target molecule, wherein a conjugate according to the second aspect is reacted with a target molecule comprising a 1,3-dipole group or a 1,3-(hetero)diene group. In a fourth aspect, the invention is directed to the use of the conjugate according to the second aspect for bioorthogonal labeling and/or modification of a target molecule.
    Type: Application
    Filed: May 10, 2024
    Publication date: September 12, 2024
    Inventors: Frank Bergmann, Dieter Heindl, Nils Winter
  • Publication number: 20240209432
    Abstract: The present disclosure relates to compositions and methods based on polypeptide-tagged nucleotide, and the use of such polypeptide-tagged nucleotides in nanopore devices and methods.
    Type: Application
    Filed: June 28, 2023
    Publication date: June 27, 2024
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Frank BERGMANN, Christoph SEIDEL, Andrew TRANS, Dmitriy GREMYACHINSKIY, Hannes KUCHELMEISTER, Lars HILLRINGHAUS
  • Publication number: 20240150824
    Abstract: The present disclosure relates to tagged nucleoside-5?-oligophosphates having a positively charged polymer tag structure and components thereof. Such nucleoside-5?-oligophosphates are useful, for example, in nanopore-based sequencing-by-synthesis applications. Also disclosed herein are nanopore constructs engineered to have additional negatively-charged moieties in the channel of the nanopore. Such nanopores can be useful, for example, for providing a repellant force against template and/or primer nucleic acids inserting into the pore during a nucleic sequence-by-synthesis process. The tagged nucleoside-5?-oligophosphates and nanopores disclosed herein can be used together to provide nanopore-based nucleic acid sequencing-by-synthesis systems and processes having reduced background tag levels and improved throughput.
    Type: Application
    Filed: August 9, 2021
    Publication date: May 9, 2024
    Inventors: Aruna Ayer, Frank Bergmann, Peter Crisalli, Lars Hillringhaus, Omid Khakshoor, Hannes Kuchelmeister, Rongxin Nie, Marshall W. Porter, Christoph Seidel, Seong-Ho Shin, Meng Taing, Adolfo Vargas
  • Patent number: 11969755
    Abstract: Described herein are a method for transferring an embossed structure, which includes at least the steps (1-i) and (2-i) or (1-ii) and (2-ii), where steps (1-i) and (2-i) or (1-ii) and (2-ii) are carried out using an embossing tool (P1) including at least one embossing die (p1), where the embossing die (p1) of the embossing tool (P1) is pretreated, before the implementation of step (2-i) or before the implementation of step (1-ii), with at least one organic solvent and/or at least one reactive diluent, and also a method of using a corresponding pretreated embossing tool (P1) including at least one embossing die (p1) for the purpose of transferring an embossed structure in such a way.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: April 30, 2024
    Assignee: BASF COATINGS GMBH
    Inventors: Jan-Bernd Kues, Susanne Piontek, Joerg Exner, Birgit Kleine-Bley, Alberto Garcia Martin, Jens-Henning Noatschk, Michael Lorenz, Robert Von Der Aa, Frank Bergmann, Wilfried Schipper
  • Publication number: 20240010668
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Application
    Filed: August 11, 2023
    Publication date: January 11, 2024
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Heindl, Omid Khakshoor, Meng Taing
  • Patent number: 11865858
    Abstract: The present disclosure relates to a method for transferring an embossed structure to a surface of a coating composition (B2a), which includes the steps (1-i) and (2-i) or (1-ii) and (2-ii) and also the steps (3) and optionally (4), where the steps (1-i) and (2-i) or (1-ii) and (2-ii) are performed using a composite (F1B1) which is employed as an embossing die (p2) of an embossing tool (P2) and which is composed of a substrate (F1) and of an at least partially embossed and at least partially cured coating (B1), and the coating composition (B1a) used for producing (B1) of the composite (F1B1) is a radiation-curable coating composition of defined constitution. Also described herein is a composite (F1B1).
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: January 9, 2024
    Assignee: BASF COATINGS GMBH
    Inventors: Jan-Bernd Kues, Susanne Piontek, Joerg Exner, Birgit Kleine-Bley, Robert von der Aa, Michael Lorenz, Frank Bergmann, Wilfried Schipper, Sven Olle Krabbenborg, Joerg Duennewald
  • Publication number: 20230332223
    Abstract: Molecules may be analyzed (e.g., sequencing of nucleic acid molecules) by tunneling recognition at a tunneling junction. Embodiments of the present invention may allow detecting individual nucleotides and the sequencing of a nucleic acid molecule using a tunneling junction. By labeling a specific nucleotide with a moiety, tunneling junctions may generate a signal with a suitable signal-to-noise ratio. The tunneling recognition uses a tunneling current that is mostly through the moiety rather than mostly through the nucleotide or a portion of the molecule of interest. Because a single nucleotide can be detected with a signal with a suitable signal-to-noise ratio resulting from the tunneling current passing through the moiety, embodiments of the present invention may allow for fast detection of nucleotides using a tunneling current.
    Type: Application
    Filed: June 26, 2023
    Publication date: October 19, 2023
    Inventors: Yann ASTIER, Juraj TOPOLANCIK, Hannes KUCHELMEISTER, Frank BERGMANN, Dieter HEINDL, Nikolaus Klaus-Peter STENGELE
  • Patent number: 11773130
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Grant
    Filed: July 6, 2022
    Date of Patent: October 3, 2023
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Heindl, Omid Khakshoor, Meng Taing
  • Patent number: 11739378
    Abstract: The present disclosure relates to compositions and methods based on polypeptide-tagged nucleotide, and the use of such polypeptide-tagged nucleotides in nanopore devices and methods.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: August 29, 2023
    Assignees: Roche Sequencing Solutions, Inc., Roche Molecular Systems, Inc.
    Inventors: Frank Bergmann, Christoph Seidel, Andrew Trans, Dmitriy Gremyachinskiy, Hannes Kuchelmeister, Lars Hillringhaus
  • Patent number: 11718870
    Abstract: Molecules may be analyzed (e.g., sequencing of nucleic acid molecules) by tunneling recognition at a tunneling junction. Embodiments of the present invention may allow detecting individual nucleotides and the sequencing of a nucleic acid molecule using a tunneling junction. By labeling a specific nucleotide with a moiety, tunneling junctions may generate a signal with a suitable signal-to-noise ratio. The tunneling recognition uses a tunneling current that is mostly through the moiety rather than mostly through the nucleotide or a portion of the molecule of interest. Because a single nucleotide can be detected with a signal with a suitable signal-to-noise ratio resulting from the tunneling current passing through the moiety, embodiments of the present invention may allow for fast detection of nucleotides using a tunneling current.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: August 8, 2023
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Yann Astier, Juraj Topolancik, Hannes Kuchelmeister, Frank Bergmann, Dieter Heindl, Nikolaus Klaus-Peter Stengele
  • Publication number: 20230159584
    Abstract: The present invention provides a new building block for peptide synthesis, which introduces a cleavage site that can be used to generate cleavable fragments subsequent to a peptide sequence.
    Type: Application
    Filed: November 15, 2022
    Publication date: May 25, 2023
    Inventors: Frank BERGMANN, Simon Ferdinand LOIBL, Sebastian Johannes POMPLUN
  • Publication number: 20230128368
    Abstract: The present disclosure relates to a set of at least 100 single-stranded oligonucleotide probes directed against (or complementary to) portions of a genomic target sequence of interest. The present disclosure also relates to a method of detecting a genomic target sequence of interest using the set of oligonucleotide probes and a method of generating the set of oligonucleotide probes. Further, the present disclosure relates to a kit comprising the set of oligonucleotide probes and at least one further component.
    Type: Application
    Filed: July 14, 2022
    Publication date: April 27, 2023
    Inventors: Frank Bergmann, Walter Eberle, Thomas Fischer, Herbert von der Eltz